Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group

The Children's Cancer Group (CCG) 1952 clinical trial for children with standard-risk acute lymphoblastic leukemia (SR-ALL) compared intrathecal (IT) methotrexate (MTX) with IT triples (ITT) (MTX, cytarabine, and hydrocortisone sodium succinate [HSS]) as presymptomatic central nervous system (C...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Matloub, Yousif, Lindemulder, Susan, Gaynon, Paul S., Sather, Harland, La, Mei, Broxson, Emmett, Yanofsky, Rochelle, Hutchinson, Raymond, Heerema, Nyla A., Nachman, James, Blake, Marilyn, Wells, Linda M., Sorrell, April D., Masterson, Margaret, Kelleher, John F., Stork, Linda C.
Format: Artigo
Język:Inglês
Wydane: The American Society of Hematology 2006
Hasła przedmiotowe:
Clinical Trials and Observations
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895867/
https://ncbi.nlm.nih.gov/pubmed/16609069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-12-011809
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy